bezafibrate has been researched along with Renal Insufficiency in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H; Iwasaki, M; Koshida, T; Matsuzaki, K; Saito, M; Suzuki, H; Suzuki, Y; Takahara, H; Umezawa, Y | 1 |
| Dohmen, K; Haruno, M; Tanaka, H | 1 |
| Hashizume, H; Horiguchi, N; Hosonuma, K; Kakizaki, S; Kusano, M; Sato, K; Yamada, M; Yamazaki, Y; Yanagisawa, M | 1 |
| Castellaneta, NM; Di Leo, A; Facciorusso, A; Licinio, R | 1 |
| Hosonuma, K; Kusano, M; Sato, K; Yamada, M | 1 |
| Fisman, EZ; Goldenberg, I; Klempfner, R; Peled, Y; Shlomo, N; Tenenbaum, A; Tzur, B; Younis, A | 1 |
| Lipkin, GW; Tomson, CR | 1 |
| Muscari, A; Puddu, GM; Puddu, P | 1 |
1 review(s) available for bezafibrate and Renal Insufficiency
| Article | Year |
|---|---|
Lipid-lowering drugs: are adverse effects predictable and reversible?
Topics: Aryl Hydrocarbon Hydroxylases; Bezafibrate; Cholesterol, LDL; Cytochrome P-450 Enzyme System; Digestive System; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver; Renal Insufficiency; Rhabdomyolysis; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2002 |
1 trial(s) available for bezafibrate and Renal Insufficiency
| Article | Year |
|---|---|
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.
Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Myalgia; Prognosis; Renal Insufficiency; Survival Rate; Time; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
6 other study(ies) available for bezafibrate and Renal Insufficiency
| Article | Year |
|---|---|
Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study.
Topics: Bezafibrate; Drug Substitution; Fenofibrate; Humans; Hypertriglyceridemia; Renal Insufficiency; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid | 2013 |
Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?
Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid | 2015 |
Response to Licinio et al.
Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid | 2015 |
Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
Topics: Age Factors; Aged; Bezafibrate; Chi-Square Distribution; Coronary Artery Disease; Female; Humans; Hypolipidemic Agents; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Registries; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors | 2016 |
Severe reversible renal failure with bezafibrate.
Topics: Bezafibrate; Humans; Male; Middle Aged; Renal Insufficiency | 1993 |